Seaport Therapeutics Inc. Common Stock
SPTX | NASDAQ
$19.60
-$1.50 (-7.11%)
At close: Oct 30, 2026, 4:00 PM ET
$19.21
-$0.39 (-1.99%)
Pre-market:
Nov 2, 2026, 7:53 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Revenue | n/a | n/a |
Cost of Revenue | 351K | n/a |
Gross Profit | -351K | n/a |
Operating Income | -65.81M | -27.54M |
Interest Income | 3.26M | 2.13M |
Pretax Income | -62.59M | -24.89M |
Net Income | -62.6M | -25.41M |
Selling & General & Admin | 40.84M | 6.11M |
Research & Development | 24.62M | 21.43M |
Other Expenses | n/a | n/a |
Operating Expenses | 65.46M | 27.54M |
Interest Expense | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 65.81M | 27.54M |
Income Tax Expense | 15K | 519K |
Shares Outstanding (Basic) | 53.53M | 53.03M |
Shares Outstanding (Diluted) | 53.53M | 53.03M |
EPS (Basic) | -1.17 | -0.48 |
EPS (Diluted) | -1.17 | -0.48 |
EBITDA | -65.46M | -27.19M |
EBIT | -65.81M | -27.54M |
Depreciation & Amortization | 351K | 357K |
Add to Watchlist
Select watchlists to add or remove SPTX